TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Y-90 Radioembolization Stabilizes Liver Metastases in 98.5 Percent Of Breast Cancer Patients in Study March 28, 2014
TCL Archive In Brief: Wittes to Join Bristol-Myers As VP; Friedman Named Acting CTEP Director; Carl Pinsky Leaves September 23, 1988